EyePoint, Inc. Share Price
NASDAQ: EYPT | Micro CapEyePoint, Inc. Stock Performance
EyePoint, Inc. Share Price Today
As of 9 October 2026, EyePoint, Inc.'s share price is $3.47. The stock opened at $3.30, compared to its previous close of $3.32. During today's trading session, EyePoint, Inc.'s share price traded between $3.27 and $3.51, with an average price of $3.39. Over the past 52 weeks, the stock has recorded a high of $18.92 and a low of $3.05. In terms of performance, EyePoint, Inc.'s share price has declined by 73.69% over the last six months and is down 73.53% on a year-on-year basis.
EyePoint, Inc. Share Price Chart
EyePoint, Inc. Quarterly Profit & Loss
All figures in USD
EyePoint, Inc. Annual Profit & Loss
All figures in USD
About EyePoint, Inc.
EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.
EyePoint, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $3.29 | $3.46 | +6.29% |
Sep 2026 | $4.41 | $3.26 | -29.36% |
Aug 2026 | $12.36 | $4.62 | -62.26% |
Jul 2026 | $14.73 | $12.23 | -14.36% |
Jun 2026 | $13.24 | $14.28 | +5.23% |
May 2026 | $13.44 | $13.57 | +2.88% |
Apr 2026 | $13.11 | $13.19 | +2.29% |
Mar 2026 | $17.54 | $12.89 | -26.55% |
Feb 2026 | $13.54 | $17.55 | +29.84% |
Jan 2026 | $18.50 | $13.52 | -26.04% |
Dec 2025 | $14.53 | $18.28 | +23.26% |
Nov 2025 | $13.26 | $14.83 | +13.12% |